The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identifying continuing educational needs among oncologists in managing patients with pancreatic cancer.
 
Wendy Cerenzia
Research Funding - Abbvie (Inst); Allergan (Inst); Astellas Pharma (Inst); Biogen (Inst); Celgene (Inst); Genentech/Roche (Inst); Genzyme (Inst); Gilead Sciences (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); Lundbeck (Inst); Novartis (Inst); Novo Nordisk (Inst); Regeneron (Inst); Sunovion (Inst); Takeda (Inst); Tesaro (Inst); Teva (Inst)
 
Sharon Hwang
No Relationships to Disclose
 
Khalid Kevin Mamlouk
Employment - Merrimack
Stock and Other Ownership Interests - Agios; Blueprint Medicines; Clovis Oncology; Jounce Therapeutics; Merrimack
Consulting or Advisory Role - Blue Earth Diagnostics; Blueprint Medicines; Ipsen
 
Beloo Mirakhur
Employment - ipsen; ipsen
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Benjamin Leon Musher
Honoraria - Celgene; Ipsen
Speakers' Bureau - Ipsen
Research Funding - Lokon Pharma